Based on a postulation algorithm that VE-cadherin-mediated VM formation would promote RCC progression, the miRNAs that target VE-cadherin and decrease in RCC (potential tumor suppressor), rather the ones that increase, might be the key candidate players (Figure 2e). The gene discussed is CDH5; the disease is renal cell carcinoma.